Next Article in Journal
Development of a Sphingosylphosphorylcholine Detection System Using RNA Aptamers
Previous Article in Journal
Study of Cyclic Quaternary Ammonium Bromides by B3LYP Calculations, NMR and FTIR Spectroscopies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 15
Issue 8
10.3390/molecules15085680
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Facile Synthesis of 3-Substituted 9H-Pyrido[3,4-b]indol-1(2H)-one Derivatives from 3-Substituted β-Carbolines

by
Guowu Lin
1,
Yue Wang
1,*,
Qingfa Zhou
1,
Weifang Tang
1,
Jian Wang
1 and
Tao Lu
1,2,*
1
College of Basic Science, China Pharmaceutical University, Nanjing 210009, China
2
Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China
*
Authors to whom correspondence should be addressed.
Molecules 2010, 15(8), 5680-5691; https://doi.org/10.3390/molecules15085680
Submission received: 2 August 2010 / Revised: 10 August 2010 / Accepted: 11 August 2010 / Published: 17 August 2010
Browse Figures
Versions Notes

Abstract

:
A mild and efficient two-step synthesis of 3-substituted β-carbolinone derivatives from 3-substituted β-carboline in good yields is described. A possible reaction mechanism for the formation of the skeleton of β-carbolin-1-one is proposed. The structures of these compounds were established by IR, 1H-NMR, 13C-NMR, mass spectrometry and elemental analysis, as well as X-ray crystallographic analysis of 4-2 and 6-2.

Introduction

Natural products have a profound impact on both chemical biology and drug discovery, and the substituted β-carboline moiety is an example. β-Carboline is a key pharmacophore present in a large number of natural tricyclic alkaloids, which can be found in numerous plants and animals, exhibiting potent biological activities [1,2,3,4,5,6,7,8,9,10]. As a key member of the β-carboline family, its structural variant tricyclic β-carbolinone (9H-pyrido[3,4-b]indol-1(2H)-one derivative or β-carbolin-1-one, Figure 1) has served as an important intermediate for the preparation of complex alkaloids [11,12,13,14,15,16,17,18,19] and has been found to possess potent bioactivities. The natural and synthetic β-carbolinones are reported to have pharmacological effects in several aspects, such as the anticancer activity against colon and lung cancers, central nervous system activity in mammals, and also as the biological control agent for receptor research on bio-enzyme inhibitors, such as the inhibition of HLE (Human leukocyte elastase) [20,21,22,23]. In continuation of our work on biologically active β-carbolinone alkaloids [24], we focused our interest on the synthesis of 3-disubstituted β-carbolinones.
Molecules 15 05680 g001 550
Figure 1. The structure of tricyclic β-carbolinones.
Figure 1. The structure of tricyclic β-carbolinones.
Molecules 15 05680 g001
The total synthesis of these substituted tricyclic β-carbolinones has attracted great attention, however, few facile synthetic approaches to β-carbolinones have been published over the years. A majority of alkaloids are substituted at the 3-position of β-carbolinones, and two major synthetic strategies have been adopted for this purpose: one approach starting from tryptamine which offers an easy access to β-carbolinone (9H-pyrido[3,4-b]indol-1(2H)-one, Scheme 1) [25], and another three step route to synthesize 3-aryl-β-carbolinone by reaction of chalcone derivatives with N-acetyl-2-cyanoglycine ethyl ester (Scheme 2) [26]. Nevertheless, it is still difficult to introduce other groups directly at the 3-position of the β-carbolinone by these methodologies, especially for the synthesis of electron-withdrawing substituents at the 3-position of β-carbolinone. So it is urgent and significant to find a new and effective way to synthesize a large number of 3-substituted (electron-withdrawing) β-carbolinones. Herein, we report a novel synthetic route for the preparation of 3-substituted (electron-withdrawing substituents) β-carbolinones.
Molecules 15 05680 g004 550
Scheme 1. A conventional route to synthesize of 9H-pyrido[3,4-b]indol-1(2H)-one.
Scheme 1. A conventional route to synthesize of 9H-pyrido[3,4-b]indol-1(2H)-one.
Molecules 15 05680 g004
Molecules 15 05680 g005 550
Scheme 2. A route to synthesize 3-aryl-9H-pyrido[3,4-b]indol-1(2H)-one.
Scheme 2. A route to synthesize 3-aryl-9H-pyrido[3,4-b]indol-1(2H)-one.
Molecules 15 05680 g005

Results and Discussion

In this paper, we describe a two-step preparation of 3-substituted β-carbolinones using 3-substituted β-carbolines as the starting materials (Scheme 3).
Molecules 15 05680 g006 550
Scheme 3. A route to synthesize 3-substituted β-carbolinones.
Scheme 3. A route to synthesize 3-substituted β-carbolinones.
Molecules 15 05680 g006
For the first step, in a mixed and refluxing 1:1 chloroform/ethanol solution, β-carboline derivatives X were treated with 3-chloro-peroxybenzoic acid (m-CPBA) yielding the corresponding N-oxides X-1 in excellent yields, which then were purified by flash column chromatography; in the second step, the β-carbolinones were obtained through the regioselective rearrangement of the β-carboline-N-oxides in acetic anhydride at refluxing and subsequently hydrolysis in a solution of EtOH/aqueous 2 M NaOH (1:1) at room temperature. The 3-substituted β-carboline substrates were synthesized according to the literature procedure [27,28,29,30,31], which is summarized in Scheme 4.
Molecules 15 05680 g007 550
Scheme 4. Synthesis of 3-substituted β-carbolines.
Scheme 4. Synthesis of 3-substituted β-carbolines.
Molecules 15 05680 g007
Based on our experimental results and other similar reactions [32,33,34,35,36,37], the reaction mechanism of β-carboline N-oxides with glacial acetic acid and sodium hydroxide was presumed to be as shown in Scheme 5. The overall process may be summarized as follows: i) β-carboline-N-oxide X-1 was refluxed with excess acetic anhydride to yield light brown syrup from which intermediate I (2-acetoxy-β-carboline derivative) was formed; ii) another acetyl oxygen anion (CH3COO-) attacks the carbon atom at 1-position of 2-acetoxy-β-carboline, and meanwhile the (C1 = N2) double bond was broken to give ntermediate II (1,2-diacetoxy-1,2-dihydro-β-carboline); iii) elimination of one molecule of acetic acid, and regeneration of the (C1 = N2) double bond to give intermediate III (1-acetoxy-β-carboline derivative)’ iv) by the hydrolysis of 1-acetoxy-β-carbolines III in sodium hydroxide solution, the target compounds were obtained via intermediate IV.
Molecules 15 05680 g008 550
Scheme 5. The possible mechanism for the synthesis of 3-substituted 9H-pyrido[3,4-b]indol-1(2H)-one derivatives.
Scheme 5. The possible mechanism for the synthesis of 3-substituted 9H-pyrido[3,4-b]indol-1(2H)-one derivatives.
Molecules 15 05680 g008
The various β-carbolines were used as substrates, and the results are summarized in Table 1. Under identical reaction conditions, using 3-ethoxycarbonyl-β-carboline, 3-hydroxymethyl-β-carboline, 3-cyano-β-carboline, β-carboline-3-carbohydrazide, or 3-(N-methylcarbamoyl)-β-carboline as starting materials, we obtained good yields (about 67-85%) of corresponding products (entries 2, 3, 5, 6 and 10 in Table 1). However, other β-carboline derivatives gave moderate yields (about 30-50%) of the corresponding β-carbolinones (entries 4, 7, 8 and 9). This discrepancy may be attributed to the different groups at the 3-position, because electron withdrawing substituents at the 3-position can enhance the electronic stability of intermediate I, and therefore, a relatively higher yield of product could be obtained. However, an electron-rich substituent is not beneficial for the electronic stability of intermediate I, so poor yield were observed in our experiments. All products were fully characterized by spectroscopic means.
Table
Table 1. Yields and times for the synthesis of 9H-pyrido[3,4-b]indol-1(2H)-one derivative.
Table 1. Yields and times for the synthesis of 9H-pyrido[3,4-b]indol-1(2H)-one derivative.
EntryR1Product (X-2)Time (h) aYield (%)b, c
1H(4-2)665
2COOCH2CH3(5-2)485
3CH2OH(6-2)875
4CHO(7-2)652
5CN(8-2)472
6 CONHNH2(9-2)467
7OCH3(12-2)1045
8OCH2CH3(13-2)1053
9Br (14-2)1230
10CONHCH3(15-2)482
a Monitored by TLC until N-oxidation is complete. b Isolated yield by column chromatography.c The yields of conversion of the N-oxides X-1 into 3-substituted β-carbolinones X-2.
At the same time, we obtained colorless platelet crystals of 4-2 from 80% (v/v) MeOH/H2O solution and 6-2 from 50% (v/v) MeOH/DMF (dimethylformamide) at room temperature (Figure 2-Figure 3) [38] for X-ray analysis.
Molecules 15 05680 g002 550
Figure 2. ORTEP drawing of the X-ray crystal structure of compound 4-2. Displacement ellipsoids were drawn at 50% probability level.
Figure 2. ORTEP drawing of the X-ray crystal structure of compound 4-2. Displacement ellipsoids were drawn at 50% probability level.
Molecules 15 05680 g002
Molecules 15 05680 g003 550
Figure 3. ORTEP drawing of the X-ray crystal structure of compound 6-2. Displacement ellipsoids were drawn at 50% probability level.
Figure 3. ORTEP drawing of the X-ray crystal structure of compound 6-2. Displacement ellipsoids were drawn at 50% probability level.
Molecules 15 05680 g003

Conclusions

We have developed a simple and efficient two-step synthetic route for the synthesis in moderate to good yields of 3-substituted β-carbolinone derivatives from 3-substituted β-carbolines, and the reagents used are not hazardous and are easy to handle. This method offered a facile way to introduce various electron-withdrawing or electron-rich substituents into β-carbolinone derivatives at 3-position, which should broaden the application scope of the β-carbolinone skeleton. This type of reaction has been widely applied in our laboratory for the preparation of 3-substituted β-carbolinone derivatives. In addition, a plausible reaction mechanism has been proposed.

Experimental

General

Unless otherwise specified, reagents were purchased from commercial suppliers and used without further purification. Reaction progress was monitored using analytical thin layer chromatography (TLC) on percolated Merck silica gel Kiesegel 60 F254 plates, and the spots were detected under UV light (254 nm). Melting points were determined with a digital melting point apparatus and are reported uncorrected. 1H-NMR and 13C-NMR spectra were recorded at 300 MHz (1H) or 75 MHz (13C) on a Bruker ARX 300 spectrometer. IR spectra were measured on a Jasco FT/IR-430 spectrophotometer. Mass spectra were recorded on an a Quattro microMS Micromass UK mass spectrometer, and was recorded on an electrospray ionization mass spectrometer as the value m/z. The X-ray measurements were made on a Rigaku RAXIS RAPID diffractometer with a graphite monochromatised Mo Kα radiation (λ= 0.71069 Å) using ω scan mode.

General Procedure for the synthesis of N-oxidation

In a 100 mL single-necked, round-bottomed flask equipped with a magnetic stirrer, β-carboline derivative (1 mmol), 3-chloroperoxybenzoic acid (670 mg, 3 mmol), CHCl3 (5 mL) and EtOH (5 mL) were added. The reaction mixture was refluxed until there were no starting materials left (TLC monitoring), then cooled to room temperature. NaOH (3 mL, 0.1 M) were added and stirring was continued for 30 min. The aqueous phase was extracted with CHCl3 (2 × 25 mL), and the combined organic phases were dried with Mg2SO4 and concentrated in vacuo. The residues were purified by flash column chromatography using an eluent MeOH-CHCl3 to give the title compound as a pale yellow solid. Other compounds were synthesized similarly and the yields and spectroscopic data of 4-1, 5-1, 6-1, 7-1, 8-1, 9-1, 12-1, 13-1, 14-1 and 15-1 were as follows.
β-Carboline-N-oxide (4-1). Yield: 175 mg (95%), pale yellow solid. ESI-MS m/z 185.10 (M + 1).
3-Ethoxycarbonyl-β-carboline-N-oxide (5-1). Yield: 238 mg (93%), pale yellow solid. ESI-MS m/z 257.45 (M + 1).
3-Hydroxymethyl-β-carboline-N-oxide (6-1). Yield: 190 mg (89%), pale yellow solid. ESI-MS m/z 215.20 (M + 1).
3-Formyl-β-carboline-N-oxide (7-1). Yield: 127 mg (60%), pale yellow solid. ESI-MS m/z 213.10 (M + 1).
3-Cyano-β-carboline-N-oxide (8-1). Yield: 188 mg (90%), pale yellow solid. ESI-MS m/z 210.05 (M + 1).
β-Carboline-3-carbohydrazide-N-oxide (9-1). Yield: 198 mg (82%), pale yellow solid. ESI-MS m/z 243.12 (M + 1).
3-Methoxyl-β-carboline-N-oxide (12-1). Yield: 160 mg (75%), pale yellow solid. ESI-MS m/z 215.05 (M + 1).
3-Ethoxy-β-carboline-N-oxide (13-1). Yield: 183 mg (80%), pale yellow solid. ESI-MS m/z 229.10 (M + 1).
3-Bromo-β-carboline-N-oxide (14-1). Yield: 174 mg (66%), pale yellow solid. ESI-MS m/z 264.15 (M + 1).
3-(N-Methylcarbamoyl)-β-carboline-N-oxide (15-1). Yield: 186 mg (87%), pale yellow solid. ESI-MS m/z 242.20 (M + 1)

General Procedure for the synthesis of 9H-pyrido[3,4-b]indol-1(2H)-one derivatives

A β-carboline N-oxide derivative (1 mmol) were dissolved in acetic anhydride (10 mL), and the mixture was heated under reflux for 6 hours until there were no starting materials left (TLC control). After being cooled to ambient temperature, the reaction mixture was concentrated under reduced pressure. The intermediate 2-acetoxy-β-carboline derivative was dissolved in EtOH/aqueous 2 M NaOH (1:1), and stirred at room temperature for 2 hours. The solvent was removed in vacuo, and the residue was purified by column chromatography using MeOH/CHCl3 as an eluent to give the title pyridoindolone.
9H-Pyrido[3,4-b]indol-1(2H)-one (4-2): Prepared from 4-1, yield 120 mg (65%), white solid, m.p. 253-255 °C. IR (KBr): 3261, 3112, 2966, 2840, 1645, 1446, 738 cm-1. ESI-MS m/z 185.05 (M + 1). 1H -NMR (DMSO-d6): δ = 11.91 (1H, s, indole), 11.35 (1H, s, -NHCO-), 8.03 (1H, d, J = 8.0 Hz, ArH), 7.50 (1H, d, J = 7.8 Hz, ArH), 7.39 (1H, t, J = 7.2 Hz, ArH), 7.17(1H, t, J = 8.0 Hz, ArH), 7.07 (1H, t, J = 7.3 Hz, ArH), 6.96 (1H, d, J = 7.0 Hz, ArH). 13C-NMR (DMSO-d6): δ = 155.8, 139.1, 128.2, 126.3, 124.6, 124.4, 122.1, 121.4, 119.6, 112.6, 99.8. Anal. Calcd for C11H8N2O: C, 71.73; H, 4.38; N, 15.21. Found: C, 71.70; H, 4.37; N, 15.23.
3-Ethoxycarbonyl-9H-pyrido[3,4-b]indol-1(2H)-one (5-2): Prepared from 5-1, yield 217 mg (85%), white solid. m.p. 257-259 °C. IR (KBr): 3380, 3128, 2985, 1701, 1652, 1298, 1249 cm-1. ESI-MS m/z 257.00 (M + 1). 1H -NMR (DMSO-d6): δ = 12.49 (1H, s, indole), 11.31 (1H, s, -NHCO-), 8.20 (1H, d, J = 8.3 Hz, ArH), 7.92 (1H, s, ArH), 7.55 (1H, d, J = 7.2 Hz, ArH), 7.46 (1H, t, J = 7.6 Hz, ArH), 7.26 (1H, t, J = 8.0 Hz, ArH), 4.30 (2H, q, J = 6.5 Hz,-OCH2), 1.30 (3H, t, J = 4.3 Hz, -CH3). 13C-NMR (DMSO-d6): δ = 161.6, 154.8, 139.5, 131.2, 126.8, 125.0, 122.7, 122.2, 121.7, 120.7, 112.9, 106.2, 61.5, 14.3. Anal. Calcd for C14H12N2O3: C, 65.62; H, 4.72; N, 10.93. Found: C, 65.60; H, 4.75; N, 10.94
3-Hydroxymethyl-9H-pyrido[3,4-b]indol-1(2H)-one (6-2): Prepared from 6-1, yield 160 mg (75%), white solid. m.p. 283-285 °C. IR (KBr): 3382, 3182, 3137, 2997, 1639, 1431, 1328, 744 cm-1; ESI-MS m/z 215.05 (M + 1). 1H-NMR (DMSO-d6): δ = 11.84 (1H, s, indole), 11.18 (1H, s, -NHCO-), 8.01 (1H, d, J = 7.9 Hz, ArH), 7.50 (1H, d, J = 7.2 Hz, ArH), 7.41 (1H, t, J = 8.0 Hz, ArH), 7.18 (1H, t, J = 7.3 Hz, ArH), 6.92 (1H, s, ArH), 5.30 (H, t, J = 6.1 Hz, -OH), 4.40 (2H, t, J = 3.5 Hz, -CH2O-). 13C-NMR (DMSO-d6) : δ = 155.9, 139.4, 138.5, 126.9, 126.2, 124.4, 122.1, 121.3, 119.5, 112.6, 96.8, 60.3. Anal. Calcd for C12H10N2O2: C, 67.28; H, 4.71; N, 13.08. Found: C, 67.31; H, 4.65; N, 13.06.
3-Formyl-9H-pyrido[3,4-b]indol-1(2H)-one (7-2): Prepared from 7-1, yield 110 mg (52%), white solid. m.p. 276-277 °C. IR (KBr): 3350, 3120, 2990, 1705, 1669, 1300 cm-1. ESI-MS m/z 213.10 (M + 1). 1H-NMR (300MHz, DMSO-d6): δ = 11.73 (1H, s, indole), 11.23 (1H, s, -NHCO-), 9.50 (2H, t, J = 7.8 Hz, -CHO), δ8.0 (1H, d, J = 8.0 Hz, ArH), 7.60 (1H, d, J = 7.2 Hz, ArH), 7.52 (1H, t, J = 7.0 Hz, ArH), 7.12 (1H, t, J = 8.1 Hz, ArH), 6.95 (1H, s, ArH). 13C-NMR (300MHz, DMSO-d6): δ = 165.1, 152.1, 142.9, 140.1, 125.6, 124.6, 121.5, 120.6, 119.9, 119.3, 115.7, 114.2. Anal. Calcd for C12H8N2O2: C, 67.92; H, 3.80; N, 13.20. Found: C, 67.90; H, 3.83; N, 13.21.
3-Cyano-9H-pyrido[3,4-b]indol-1(2H)-one (8-2): Prepared from 8-1, yield 150 mg (72%), white solid. m.p. 259-261 °C. IR (KBr): 3290, 3106, 2987, 2230, 1650, 1228 cm-1. ESI-MS m/z 210.30 (M + 1). 1H-NMR (DMSO-d6): δ = 12.05 (1H, s, indole), 11.31 (1H, s, -NHCO-), 8.11 (1H, d, J = 8.0 Hz, ArH), 7.69 (1H, d, J = 7.8 Hz, ArH), 7.45 (1H, t, J = 7.6 Hz, ArH), 7.20 (1H, t, J = 8.2 Hz, ArH), 6.93 (1H, s, ArH). 13C-NMR (DMSO-d6): δ = 155.3, 145.2, 138.1, 126.9, 125.8, 124.4, 122.9, 121.6, 119.6, 119.0, 115.7, 115.2. Anal. Calcd for C12H7N3O: C, 68.89; H, 3.37; N, 20.09. Found: C, 68.90; H, 3.33; N, 20.11.
9H-Pyrido[3,4-b]indol-1(2H)-one-3-carbohydrazide (9-2): Prepared from 9-1, yield 190 mg (67%), white solid. m.p. 303-305 °C. IR (KBr): 3386, 3251, 3053, 2979, 2935, 1718, 1629, 1245, 738 cm-1. ESI-MS m/z 243.30 (M + 1). 1H-NMR (DMSO-d6): δ = 12.13 (1H, s, indole), 11.70 (1H, s, -NHCO-), 9.01(1H, s, -NH), 8.05 (1H, d, J = 7.9 Hz, ArH), 7.45 (1H, d, J = 7.0 Hz, ArH), 7.39 (1H, t, J = 8.0 Hz, ArH), 7.10 (1H, t, J = 7.9 Hz, ArH), 6.90 (1H, s, ArH), 4.50(2H, s, -NH2). 13C-NMR (DMSO-d6): δ = 167.2, 153.2, 142.8, 139.5, 126.5, 122.4, 121.9, 121.3, 119.9, 119.6, 114.7, 111.4. Anal. Calcd for C12H10N4O2: C, 59.50; H, 4.16; N, 23.13. Found: C, 59.48; H, 4.19; N, 23.12.
3-Methoxy-9H-pyrido[3,4-b]indol-1(2H)-one (12-2): Prepared from 12-1, yield 96 mg (45%), white solid. m.p. 180-181 °C. IR (KBr): 3360, 3120, 2860, 1665, 1290, 1050 cm-1. ESI-MS m/z 215.00 (M + 1). 1H-NMR (DMSO-d6): δ = 11.62 (1H, s, indole), 11.50 (1H, s, -NHCO-), 7.98 (1H, d, J = 7.8 Hz, ArH), 7.42 (1H, d, J = 8.1 Hz, ArH), 7.35 (1H, t, J = 7.2 Hz, ArH), 7.10 (1H, t, J = 8.1 Hz, ArH), 6.33 (1H, s, ArH), 3.80 (3H, s, -OCH3). 13C-NMR (DMSO-d6): δ = 156.5, 152.0, 142.1, 139.5, 124.5, 122.4, 121.9, 120.6, 119.6, 114.7, 104.1, 60.5. Anal. Calcd for C12H10N2O2: C, 67.28; H, 4.71; N, 13.08. Found: C, 67.30; H, 4.70; N, 13.07.
3-Ethoxy-9H-pyrido[3,4-b]indol-1(2H)-one (13-2): Prepared from 13-1, yield 120 mg (53%), white solid. m.p. 183-184 °C. IR (KBr): 3365, 3250, 2900, 1640, 1300, 1100 cm-1. ESI-MS m/z 229.00 (M + 1). 1H-NMR (DMSO-d6): δ = 11.71 (1H, s, indole), 11.43 (1H, s, -NHCO-), 8.05 (1H, d, J = 8.0 Hz, ArH), 7.45 (1H, d, J = 7.3 Hz, ArH), 7.37 (1H, t, J = 7.9 Hz, ArH), 7.10 (1H, t, J = 8.0 Hz, ArH), 6.55 (1H, s, ArH), 4.0 (2H, q, J = 4.6 Hz, -OCH2) , 1.3 (3H, t, J = 5.1 Hz, -CH3). 13C-NMR (DMSO-d6): δ = 156.7, 152.2, 142.5, 139.3, 125.0, 122.3, 121.7, 120.8, 119.6, 115.3, 103.6, 69.0, 19.7. Anal. Calcd for C13H12N2O2: C, 68.41; H, 5.30; N, 12.27. Found: C, 68.20; H, 5.55; N, 12.23.
3-Bromo-9H-pyrido[3,4-b]indol-1(2H)-one (14-2): Prepared from 1 4-1, yield 80 mg (30%), pale yellow solid. m.p. 270-271 °C. IR (KBr): 3382, 3207, 2921, 1660, 1299 cm-1; ESI-MS m/z 264.50 (M + 1). 1H-NMR (DMSO-d6): δ = 12.13 (1H, s, indole), 11.45 (1H, s, -NHCO-), 8.00 (1H, d, J = 7.7 Hz, ArH), 7.54 (1H, d, J = 8.0 Hz, ArH), 7.41 (1H, t, J = 8.7 Hz, ArH), 7.05 (1H, t, J = 7.2 Hz, ArH), 6.67 (1H, s, ArH). 13C-NMR (DMSO-d6): δ = 155.7, 141.9, 139.6, 126.3, 122.0, 121.8 120.4, 119.7, 116.7, 114.5, 109.3. Anal. Calcd for C11H7BrN2O: C, 50.22; H, 2.68; N, 10.65. Found: C, 50.20; H, 2.69; N, 10.67.
3-(N-Methylcarbamoyl)-9H-pyrido[3,4-b]indol-1(2H)-one (15-2): Prepared from 15-1, yield 197 mg (82%), white solid. m.p. 282-283 °C. IR (KBr) 3360, 3320, 3280, 2990, 1710, 1660, 1314 cm-1; ESI-MS m/z 242.20 (M + 1). 1H-NMR (DMSO-d6): δ = 11.70 (1H, s, indole), 11.25 (1H, s, -NHCO-), 8.88 (1H, s, -CONHCH3), 8.05 (1H, d, J = 8.0 Hz, ArH), 7.55 (1H, d, J = 7.9 Hz, ArH), 7.45 (1H, t, J = 7.2 Hz, ArH), 7.20 (1H, t, J = 7.6 Hz, ArH), 6.85 (1H, s, ArH), 2.80 (3H, d, J = 4.3 Hz, -CH3). 13C-NMR (DMSO-d6): δ = 162.7, 155.3, 141.9, 127.7, 123.2, 121.8, 121.5,121.1, 119.9, 118.8, 114.3, 112.7, 36.2. Anal. Calcd for C13H11N3O2: C, 64.72; H, 4.60; N, 17.42. Found: C, C, 64.75; H, 4.58; N, 17.40.

Acknowledgements

We are grateful to the National Natural Science Foundation of China (No. 30973609) and the Fundamental Research Funds for the Central Universities（Program No. 2J10004) for financial support.

References and Notes

  1. Abramovitch, R. A.; Spenser, I. D. The carbolines. Adv. Het. Chem. 1964, 3, 79–207. [Google Scholar]
  2. Stuart, K.; Woo-Ming, R. β-Carboline alkaloids. Heterocycles 1975, 3, 223–264. [Google Scholar] [CrossRef]
  3. Smith, T. A. Tryptamine and related compounds in plants. Phytochemistry 1977, 16, 171–175. [Google Scholar] [CrossRef]
  4. Allen, J. R. The simple β-carboline alkaloids. Phytochemistry 1980, 19, 1573–1582. [Google Scholar]
  5. Braestrup, C.; Nielsen, M.; Olsen, C. E. Urinary and brain β-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc. Natl. Acad. Sci. USA 1980, 77, 2288–2292. [Google Scholar] [CrossRef]
  6. Schlecker, W.; Huth, A.; Ottow, E.; Mulzer, J. Regioselective metalation of 9-methoxymethyl-β-carboline-3-carboxamides with amidomagnesium chlorides. Synthesis 1995, 1225–1227. [Google Scholar]
  7. Molina, P.; Fresneda, P. M. Iminophosphorane-mediated annelation of a pyridine or pyrimidine ring into an indole ring: Synthesis of β-, r-carbolines and pyrimido[4,5-b]indole derivatives. J. Chem. Soc., Perkin Trans. 1988, 7, 1819–1822. [Google Scholar]
  8. Molina, P.; Fresneda, P. M.; Zafra, G. S.; Almendros, P. Iminophosphorane-mediated syntheses of the fascaplysin alkaloid of marine origin and nitramarine. Tetrahedron Lett. 1994, 35, 8851–8854. [Google Scholar]
  9. Dodd, H. R.; Ovannes, C.; Robert, G.; Potier, P. Hybrid molecules: Growth inhibition of leishmania donovani promastigotes by thiosemicarbazones of 3-carboxy-.beta.- carbolines. J. Med. Chem. 1989, 32, 1272–1276. [Google Scholar] [CrossRef]
  10. Srivastava, S. K.; Agarwal, A.; Chauhan, P. M. S.; Agarwal, S. K.; Bhaduri, A. P.; Singh, S. N.; Fatima, N.; Chatterjee, R. K. Potent 1,3-disubstituted-9H-pyrido[3,4-b]indoles as new lead compounds in antifilarial chemotherapy. J. Med. Chem. 1999, 42, 1667–1672. [Google Scholar]
  11. Reinecke, M. G.; Newsom, J. G.; Almqvist, K. A. An Improved Synthesis of Thiophene-2,3-dicarboxylic Acid by Sequential Carboxylation. Synthesis 1980, 1980, 327–328. [Google Scholar] [CrossRef]
  12. Bracher, F.; Hildebrand, D. 1,9-Dimetalated β-carbolines. Versatile building blocks for the total synthesis of Alkaloids. Tetrahedron 1994, 50, 12329–12336. [Google Scholar] [CrossRef]
  13. Franz, B.; Dirk, H.; Ludger, E. beta-Carboline Alkaloids. 5. Total Synthesis of the Antimicrobial Marine Alkaloid Eudistomin T. Archiv der Pharmazie 1994, 327, 121–122. [Google Scholar] [CrossRef]
  14. Choshi, T.; Matsuya, Y.; Okita, M.; Inada, K.; Sugino, E.; Hibino, S. The first total synthesis of the novel [beta]-carboline alkaloid oxopropaline G. Tetrahedron Lett. 1998, 39, 2341–2344. [Google Scholar]
  15. Campos, J.; Núñez, M. d. C.; Rodríguez, V.; Gallo, M. A.; Espinosa, A. QSAR of 1,1'-(1,2-ethylenebisbenzyl)bis(4-substitutedpyridinium) dibromides as choline kinase inhibitors: a different approach for antiproliferative drug design. Bioorg. Med. Chem. Lett. 2000, 10, 767–770. [Google Scholar]
  16. Kanekiyo, N.; Choshi, T.; Kuwada, T.; Sugino, E.; Hibino, S. The First Total Synthesis of (R )-(-)-Pyridindolol K2 and Its Enantiomer. Heterocycles 2000, 53, 1877–1880. [Google Scholar] [CrossRef]
  17. Choshi, T.; Kuwada, T.; Fukui, M.; Matsuya, Y.; Sugino, E.; Hibino, S. Total syntheses of novel cytocidal beta-carboline alkaloids, oxopropalines D and G. Chem Pharm Bull (Tokyo) 2000, 48, 108–113. [Google Scholar] [CrossRef]
  18. Kanekiyo, N.; Kuwada, T.; Choshi, T.; Nobuhiro, J.; Hibino, S. Total Syntheses of beta-Carboline Alkaloids, (R)-(-)-Pyridindolol K1, (R)-(-)-Pyridindolol K2, and (R)-(-)-Pyridindol. J. Org. Chem. 2001, 66, 8793–8798. [Google Scholar] [CrossRef]
  19. Sherif, A. F. R.; Ahmed, M. F.; Farid, S. G. S.; Mona, M. E.-S.; Sigurd, E.; Jochen, L. Synthesis and 5-HT2A Antagonist Activity of Derivatives of the Novel Heterocycles Indolo[3,2-d]pyrrolo[3,2-g]azecine and Benzo[d]pyrrolo[3,2-g]azecine compared to the Benz[d]indolo[2,3-g]azecine Derivative LE 300. Arch. Pharm. 2001, 334, 241–247. [Google Scholar] [CrossRef]
  20. Veale, C. A.; Damewood, J. R.; Steelman, G. B.; Bryant, C.; Gomes, B.; Williams, J. Non-peptidic inhibitors of human leukocyte elastase .4. design, synthesis, and in vitro and in vivo activity of a series of .beta.-carbolinone-containing trifluoromethyl ketones. J. Med. Chem. 1995, 38, 86–97. [Google Scholar] [CrossRef]
  21. Ritzeler, O., Dr; Castro, A., Dr; Grenler, L.; Soucy, F. Substituted beta-carbolines as lkB kinase inhibitors. EP Pat. 1134221 (A1), 2001. [Google Scholar]
  22. Nielsch, U.; Sperzel, M.; Bethe, B.; Junge, B.; Lieb, F.; Velten, R. Treating tumor necrosis factor mediated inflammatory disease, e.g. arteriosclerosis, using new or known beta-carboline derivatives. DE Pat. 19807993 (A1), 1999. [Google Scholar]
  23. Menta, E.; Pescalli, N.; Spinelli, S. 1H-pirido[3, 4-b]indol-1-one derivavives. WO Pat. 2001/009129, 2001. [Google Scholar]
  24. Lu, T.; Lin, G. W.; Chen, Y. D.; Wang, Y.; Zhang, L. Y.; Sun, N. Y.; Hao, L. H.; Zhu, Y. Preparation of β-carbolines as cyclin-dependent kinase 2 inhibitors. CN Patent 101475571 A, 2009. [Google Scholar]
  25. Bracher, F.; Hildebrand, D. β-carboline-Alkaloide, Synthese von 1-Aryl- and 1-Alkenyl-β-carbolinen durch Palladium-katalysierte Kupplungsreak tionen. Liebigs Ann. Chem. 1992, 1315–1319. [Google Scholar] [CrossRef]
  26. Hu, Y. F.; Wang, S. Z.; Ge, Z. M.; Shi, H. J.; Lu, J. Preparation method and application of 3-aryl-β-carboline-ones. CN. Patent 1611500A, 2003. [Google Scholar]
  27. Eric, D. C.; Hernando, D. A.; Qi, H.; Mundla, S. R.; Chunrong, M.; Brad, H.; Ruth, M.; Phil, S. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors. J. Med. Chem. 1998, 41, 2537–2552. [Google Scholar] [CrossRef]
  28. Sanjay, K. S.; Alka, A.; Prem, M. S. C.; Shiv, K. A.; Amiya, P. B.; Som, N. S.; Nigar, F.; Ranjit, K. C. Potent 1,3-disubstituted-9H-pyrido[3,4-b]indoles as new lead compounds in antifilarial chemotherapy. J. Med. Chem. 1999, 42, 1667–1672. [Google Scholar] [CrossRef]
  29. Michael, C.; Robert, W. W.; Fil, G.; James, M. C.; Steven, A. B.; Kenner, C. R.; Jacqueline, N. C.; Steven, M. P.; Phil, S. β-Carbolines: Synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors. J. Med. Chem. 1982, 25, 1081–1091. [Google Scholar] [CrossRef]
  30. Klaus, P. L.; Walter, G. S.; Wolfgang, W.; Walter, E. M. β-Carbolines as benzodiazepine receptor ligands. 1. Synthesis and benzodiazepine receptor interaction of esters of β-carboline-3-carboxylic acid. J. Med. Chem. 1983, 26, 499–503. [Google Scholar] [CrossRef]
  31. Robert, H. D.; Catherine, O.; Lia, P. C.; Anne, V.; Patrice, V.; Georges, C.; Jean, R.; Pierre, P. 3-Amino-β-carboline derivatives and the benzodiazepine receptor. Synthesis of a selective antagonist of the sedative action of diazepam. J. Med. Chem. 1985, 28, 824–828. [Google Scholar] [CrossRef]
  32. Shunsaku, S.; Katsunori, T. Furopyridines. XIX[1]. Reaction of furo[2,3-b]-, -[3,2-b]-, -[2,3-c]- and -[3,2-c]pyridine with acetic anhydride. J. Heterocyclic Chem. 1996, 33, 647–654. [Google Scholar] [CrossRef]
  33. Seiji, Y.; Masahide, K.; Keiko, O.; Hajime, Y.; Yoshiro, H.; Shunsaku, S. Furopyridines. XXVII[1]. Reaction of 2-methyl and 2-cyano derivatives of furo[2,3-b]-, -[3,2-b]-, -[2,3-c]- and -[3,2-c]pyridine. J. Heterocyclic Chem. 1998, 33, 1237–1247. [Google Scholar]
  34. Choshi, T.; Matsuya, Y.; Okita, M.; Inada, K.; Sugino, E.; Hibino, S. The first total synthesis of the novel [beta]-carboline alkaloid oxopropaline G. Tetrahedron Lett. 1998, 39, 2341–2344. [Google Scholar]
  35. Kanekiyo, N.; Choshi, T.; Kuwada, T.; Sugino, E.; Hibino, S. The First Total Synthesis of (R )-(-)-Pyridindolol K2 and Its Enantiomer. Heterocycles 2000, 53, 1877–1880. [Google Scholar] [CrossRef]
  36. Kanekiyo, N.; Kuwada, T.; Choshi, T.; Nobuhiro, J.; Hibino, S. Total Syntheses of beta-Carboline Alkaloids, (R)-(-)-Pyridindolol K1, (R)-(-)-Pyridindolol K2, and (R)-(-)-Pyridindol. J. Org. Chem. 2001, 66, 8793–8798. [Google Scholar] [CrossRef]
  37. Engler, T. A.; Wanner, J. Lewis Acid-Directed Cyclocondensation of Piperidone Enol Ethers with 2-Methoxy-4-(N-phenylsulfonyl)-1,4-benzoquinoneimine: A New Regioselective Synthesis of Oxygenated Carbolines. J. Org. Chem. 2000, 65, 2444–2457. [Google Scholar] [CrossRef]
  38. CCDC 749299 and 771291 contains the supplementary crystallographic data of compounds 4-2 and 6-2. Available online: www.ccdc.cam.ac.uk/data_request/cif/ accessed on 17 August 2010. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre Via.
  • Sample Availability: Not available.

Share and Cite

MDPI and ACS Style

Lin, G.; Wang, Y.; Zhou, Q.; Tang, W.; Wang, J.; Lu, T. A Facile Synthesis of 3-Substituted 9H-Pyrido[3,4-b]indol-1(2H)-one Derivatives from 3-Substituted β-Carbolines. Molecules 2010, 15, 5680-5691. https://doi.org/10.3390/molecules15085680

AMA Style

Lin G, Wang Y, Zhou Q, Tang W, Wang J, Lu T. A Facile Synthesis of 3-Substituted 9H-Pyrido[3,4-b]indol-1(2H)-one Derivatives from 3-Substituted β-Carbolines. Molecules. 2010; 15(8):5680-5691. https://doi.org/10.3390/molecules15085680

Chicago/Turabian Style

Lin, Guowu, Yue Wang, Qingfa Zhou, Weifang Tang, Jian Wang, and Tao Lu. 2010. "A Facile Synthesis of 3-Substituted 9H-Pyrido[3,4-b]indol-1(2H)-one Derivatives from 3-Substituted β-Carbolines" Molecules 15, no. 8: 5680-5691. https://doi.org/10.3390/molecules15085680

Article Metrics

Back to TopTop